MAP2K7 and cancer: While adaptive resistance can involve broader changes in a cancer cell's transcriptional landscape like kinome reprogramming [16], we are focused on the adaptive responses that involve reactivation of initially inhibited oncogenic pathways like the MEK/ERK and PI3K/AKT [17].